The ADHD medication shortage is a disgrace to the American people as a whole. The DEA is clearly limiting resources to medications on a National scale that is impacting the entire diagnosed population. In recent months, patients have reported problems filling nearly every type of ADHD medication. What’s stranger is that no one seems to know why. Is it some kind of supply chain issue? A pandemic-era surge in demand? A government crackdown?
Official explanations have offered little clarity. The American Society of Health Pharmacists reports shortages of multiple ADHD drugs but says manufacturers have given no explanation. Meanwhile, the Drug Enforcement Administration (DEA), which controls the supply of the drugs, announced last month that it would not increase manufacturing quotas for 2023, despite the shortage- again, without providing a reason.
The DEA is restricting access to stimulant medications and is leaving patients in turmoil that need these medications to function in society. Is there a hard limit on the number of people who deserve care? How many patients is the DEA willing to refuse treatment before it considers revising its quotas? Who will hold them accountable to the lives they are disrupting?